Immucell Corp (ICCC) is a publicly traded Healthcare sector company. As of May 21, 2026, ICCC trades at $9.88 with a market cap of $89.65M and a P/E ratio of -140.91. ICCC moved -4.90% today. Year to date, ICCC is +63.31%; over the trailing twelve months it is +78.34%. Its 52-week range spans $3.38 to $10.25. Rallies surfaces ICCC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded ICCC stock?
Rallies tracks politician and congressional stock disclosures for ICCC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
te Boekhorst Paul Francis Olivier bought 2.43K (~$13.38K) on Dec 4, 2025.
te Boekhorst Paul Francis Olivier bought 3.60K (~$18.15K) on Dec 3, 2025.
te Boekhorst Paul Francis Olivier bought 2.56K (~$12.79K) on Dec 3, 2025.
ICCC Analyst Consensus
ICCC analyst coverage data. Average price target: $0.00.
Common questions about ICCC
Which politicians traded ICCC stock?
Rallies tracks politician and congressional stock disclosures for ICCC, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ICCC?
Yes. Rallies tracks politician and congressional stock disclosures for ICCC, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ICCC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ICCC. It does not provide personalized investment advice.
